Acute ischemic stroke • MiR-30d-5p • Microglial/macrophage polarization • Autophagy • Exosome Abstract Background/Aims: Recent studies have indicated that exosomes secreted from adiposederived stem cells (ADSCs) have important effects in the treatment of ischemic injury. However, the treatment mechanism is unclear. This study aimed to investigate whether ADSC-derived exosomes enriched with microRNA (miR)-30d-5p have a protective effect on acute ischemic stroke (AIS). Methods: In the current study, inflammatory factors and miR-30d-5p expression were assessed in 70 subjects with AIS and 35 healthy controls. Exosomes were characterized by transmission electron microscopy and further examined using nanoparticle tracking analyses. A rat model of AIS and an in vitro model of oxygen-and glucose-deprived (OGD) primary microglia were established to study the protective mechanism of exosomes from miR-30d-5p-overexpressing ADSCs in ischemia-induced nerve injury. Results: The results showed that following AIS, the expression of inflammatory cytokines increased, while the antiinflammatory cytokines IL-4, IL-10, and miR-30d-5p decreased both in patients and in animal models. Moreover, in vitro studies demonstrated that suppression of autophagy significantly reduced the OGD-induced inflammatory response. In addition, exosome treatment was more effective in suppressing the inflammatory response by reversing OGD-induced and Our results suggest that miR-30d-5p-enhanced ADSC-derived exosomes prevent cerebral injury by inhibiting autophagy-mediated microglial polarization to M1.
Introduction
Stroke is one of the leading causes of death worldwide and results in disabilities in approximately 75% of its survivors [1, 2] . Increasing evidence has shown that the changed microenvironment in cerebral tissue plays an important role in cerebral injury after ischemia, particularly the inflammatory response [3] . Microglial activation and promotion of M1 microglial/macrophage polarization play central roles in neuroinflammation after brain injury [4, 5] . Microglia/macrophages are known to have different phenotypes with distinct functions during the course of ischemic brain injury [5] . M2 microglia protect neighboring cells by removing cell debris and releasing trophic factors for brain repair, based on their ability to produce interleukin 4 (IL-4) and IL-10 [6] . Meanwhile chronically-activated M1 microglia exacerbate brain injury by producing neurotoxic substances, although they participate in clearing cell debris in the early stages after stroke [7] . Microglia/macrophage phenotype polarization is likely dependent on activation status, and balancing this polarization is a promising therapeutic strategy for stroke treatment.
Autophagy is a homeostatic process that can prevent damage to healthy cells [8] . Autophagy not only contributes to human physiological events, but also can paradoxically cause some pathological conditions [9] . Recently, there has been increased evidence that autophagic dysfunction could be implicated in the development of neuro-degenerative diseases, cancer, infection and diseases of aging [10, 11] . However, it is unclear whether autophagy acts primarily on the inflammatory response relative to microglia/macrophage polarization.
MicroRNAs (miRNAs), a family of non-coding RNAs of 20-25 nucleotides, play pivotal roles during this remodeling process by regulating target genes at the post-transcriptional level [12, 13] . Several studies have demonstrated significant alterations in the cerebral "miRNA-ome" following ischemia [14, 15] . These reports suggest that miRNAs may act as innovative gene therapeutic candidates contributing to neurogenesis, angiogenesis, and neural plasticity [16, 17] . A clinical study found that miR-30d-5p was downregulated in the brain cortex after hypoxia-ischemia and this miRNA is known to play an important role in regulation of autophagy and apoptosis in developing rat brains after hypoxic-ischemic injury [18] . Bioinformatics analysis (http://www.targetscan.org/) found that the expression of miR-30d-5p can target Beclin-1 and Atg5, suggesting that the expression of miR-30d-5p may play an important role in suppression of autophagy.
Mesenchymal stromal cells (MSCs) have been extensively investigated for their therapeutic properties after ischemic injury via paracrine/endocrine mechanisms [19, 20] . Exosomes (Exos) derived from MSCs have been described as a novel pathway of cell-to-cell interaction and a crucial point in signal regulation [21] [22] [23] . These membranous structures which deliver exogenous functional mRNA and miRNA sequences to target cells contribute to disease progression and can help to treat diseases. However, few studies of Exos have focused on their miRNA regulatory function in acute ischemic stroke (AIS). In the current study, we evaluated the therapeutic effect of exosomes secreted by adipose-derived stem cells (ADSCs) overexpressing miR-30d-5p on the ischemia-induced cerebral injury in AIS rats.
Materials and Methods
Clinical specimen collection and ethics statement All patients were diagnosed as having an AIS according to the World Health Organization criteria [24] ; all presented with their first episode of cerebral infarction and received treatment within 48 hours after hospitalization in the Department of Neurology of the Pudong New Area Gongli Hospital. The control group was selected from 30 patients without acute cerebral infarction. Patients with the following conditions were excluded from both groups of the present study: liver/kidney dysfunction, heart failure, severe infection, malignant disease, symptoms of potential infection in the past 4 weeks, and surgical or trauma history, or consumption of aspirin, lipid-lowering drugs (statin), or antihypertensive drugs (angiotensin converting enzyme inhibitors) within the last 2 weeks. Peripheral blood samples were obtained from 70 patients with AIS and 35 healthy volunteers ( Table 1) . Expression of the inflammatory factors inducible nitric oxide synthase (iNOS), IL-6, IL-1β, IL-4, IL-10 and tumor necrosis factor (TNF)-α in serum were measured using commercially-available ELISA kits (Sen-Xiong Company, Shanghai, China). The expression of miR-30d-5p in serum was detected by realtime polymerase chain reaction (RT-PCR). The study was approved by the ethics committee of Pudong New Area Gongli Hospital. All participants or their relatives were informed of the study and signed the consent forms before inclusion in the study.
Animals and ethics statement
Male Sprague-Dawley rats (230-280 g) were purchased from Shanghai Sippr Bk Laboratory Animals Co. Ltd. (Shanghai, China). All rats were allowed free access to food and water under controlled conditions (12/12 h light/dark cycle with humidity of 60 ± 5%, and a temperature of 22 ± 3 °C). All animals were treated in accordance with the Guide for the Care and Use of Laboratory Animals, and all experiments were approved and performed according to the guidelines of the Ethics Committee of Pudong New Area Gongli Hospital, Shanghai, China. All surgical procedures were performed under anesthesia, and every effort was made to minimize suffering. Rats were anesthetized by intraperitoneal injection of sodium pentobarbital (30 mg/kg).
Microglia isolation and culture
Neonatal rats were anesthetized, fully disinfected with 75% alcohol under anesthesia, then placed on ice and decapitated. The whole brain was dissected to obtain mixed glia cells. The meninges and blood vessels were removed carefully using ophthalmic forceps, then brain tissues were minced using ophthalmic scissors, and enzymatically digested using 0.125% trypsin at 37 °C for 60 min. Samples were separated by centrifugation at 1, 200 × g for 10 min and filtered through a 70 μm cell strainer. The mixed cells were cultured in 25 cm 2 flasks which had been coated with poly-L-lysine (PLL). Each flask contained 6 mL DMEM/ F12 medium (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) containing 10% FBS (Gibco) and 1% Pen/Strep (Solarbio, Beijing, China). Cell concentration was approximately 10 6 cells/mL calculated using a hemocytometer. The cells were cultured in a constant-temperature incubator (Sanyo, Osaka, Japan) containing 5% CO 2 at 37 °C. After culture for 7-9 days, microglia were isolated from the mixed glia by gentle shaking [25] . 
Transfection of cells with the miR-30d-5p mimic vector
For miR-30d-5p overexpression, the miR-30d-5p mimic or corresponding negative control (miR-NC) were purchased from GenePharma (Shanghai, China). ADSCs were transfected with either the miR-30d-5p mimic or miR-NC at a final concentration of 50 nM using Lipofectamine ® 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Cells were used for miR-30d-5p expression analysis or other experiments after 48 h of transfection.
RNA and miRNA extraction and real-time polymerase chain reaction Total RNA was isolated from serum or cells using Trizol reagent. First strand cDNA was synthesized using the PrimeScript™ RT Master Mix (Perfect Real Time) Kit (RR036A, Takara Bio Inc., Shiga, Japan), which was then used for RT-PCR, together with forward and reverse primers and the Power SYBR Green PCR Master Mix (Life Technologies, Thermo Fisher Scientific). U6 was used as the internal control. The primer sequences were: U6 (sense 5′-GCTTCGGCAGCACATATACTAAAAT-3', antisense 5'-CGCTTCACGAATTTGCGTGTCAT-3') and miR-30d-5p (sense 5'-GCCTGTAAACATCCCCGAC-3', antisense 5'-GTGCGTGTCGTGGAGTCG-3'). Quantification of miR-30d-5p and endogenous control mRNA U6 were performed using TaqMan assays. Data were analyzed using the 2 −ΔΔCt method.
Enzyme-linked immunosorbent assay (ELISA)
The inflammatory factors iNOS, IL-6, IL-1β, IL-4, IL-10 and TNF-α in serum or cell supernatant were measured using a commercially-available ELISA kit (Sigma-Aldrich, St Louis, MO, USA). All procedures were performed according to the manufacturer's instructions.
ADSCs isolation and characterization
Adipose tissue was harvested from normal SD rat. Then, the tissue was washed with phosphatebuffered saline (PBS) and mechanically chopped before digestion with 0.2% collagenase I (Sigma) for 1 h at 37 °C with intermittent shaking. The digested tissue was washed with Dulbecco's modified Eagle's medium (DMEM) (Sigma) containing 15% fetal bovine serum (FBS), and then centrifuged at 1000 rpm for 10 min to remove mature adipocytes. The cell pellet was resuspended in DMEM supplemented with 15% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin in a 37°C incubator with 5% CO 2 . ADSCs reaching 80%-90% confluency were detached with 0.02% ethylenediaminetetaacetic acid (EDTA)/0.25% trypsin (Sigma-Aldrich) for 5 min at room temperature and then replated. For phenotypic analysis, fluorescein isothiocyanate (FITC-F) or phycoerythrin (PE) were used. The expression of the following markers was investigated: CD29, CD90, CD44, CD105, and vWF. An IgG-matched isotype served as the internal control for each antibody. For normoxic cultures, ADSCs were cultured in 95% air (20% O 2 ) and 5% CO 2 .
Exosome isolation and characterization
Exosomes were purified from the cell culture supernatant of ADSCs (ADs-Exos). Prior to collection of culture medium, ADSCs were washed twice with phosphate-buffered saline (PBS), and the medium was changed to serum-free medium. After incubation for 48 h, the supernatant was collected and treated by sequential ultracentrifugation at 2, 000 × g for 30 min, 10, 000 × g for 30 min, and 100, 000 × g for 4 h at 4 °C. To avoid contamination with FBS-derived exosomes, exosome-free FBS (Gibco) was used to culture ADSCs. The isolated exosomes were washed once with PBS and resuspended for further characterization.
To analyze the size distribution of ADs-Exos, Nanosizer™ technology (Malvern Instruments, Malvern, UK) was adopted. For transmission electron microscopy (TEM), purified exosomes from ADSCs were resuspended in PBS and imaged as detailed previously [26] . The proteins encapsulated into exosomes were analyzed by classical western blotting to test for the specific exosome markers CD9, CD63, CD81, and TSC101
Exosome labeling and uptake Exosomes were labeled with a DiI fluorescent labeling kit (Sigma-Aldrich). DiI (400 μL) was added to the exosome suspension and incubated for 5 min at room temperature. The reaction was stopped by the addition of an equal volume of exosome-depleted bovine serum albumin and then the exosomes were washed twice with PBS to remove any unbound dye. Subsequently, the DiI-labeled or denatured exosomes were incubated with primary microglia for 24 h or sacrificed 3 h after intravenous injection through the tail vein into ischemic rats. The cells or brain slices were then fixed and stained with 4',6-diamidino-2-phenylindole (DAPI). The images were obtained under a confocal microscope. 
Oxygen and glucose deprivation (OGD) treatment
Combined oxygen and glucose deprivation was performed as described previously [27] . Briefly, ischemia was induced by changing the cells into an ischemia-mimetic solution-Hanks' solution (140 mM NaCl, 3.5 mM KCl, 0.43 mM KH 2 PO 4 , 1.25 mM MgSO 4 , 1.7 mM CaCl 2 , 5 mM NaHCO 3 , 20 mM HEPES, pH 7.2-7.4) and placing the culture dishes in a hypoxic incubator chamber (Billups-Rothenberg, San Diego, CA, USA) equilibrated with 95% N 2 /5% CO 2 at 37 °C for 6 h. The buffered Hanks' solution was previously gassed with 95% N 2 /5% CO 2 for 30 min. The exosome treatment groups were treated with 10 μg/mL exosomes from ADSCs or miR-30d-5p added into the Hanks' solution. The 3-methyladenine (3-Ma) treatment group was treated with 2 mM 3-Ma in Hanks' solution. Control cells incubated in DMEM/F12 were run in parallel for each condition for the corresponding period of time.
Immunofluorescence Cells or tissues were incubated with LC-3, Iba-1, CD206, iNOS antibodies or TUNEL (InvivoGen, San Diego, CA, USA) overnight at 4 °C, then incubated with conjugated secondary antibody for 1 h at room temperature in the dark. After several washes with PBS, the slides were incubated with DAPI for 3 min and then mounted in glycerol. The fluorescence was assessed under a fluorescence microscope.
Luciferase reporter assay
To construct luciferase reporter vectors, the 3'-UTR of Atg5 and Beclin-1 cDNA fragments containing the predicted potential miR-30d-5p binding sites were amplified by PCR and subcloned downstream of the luciferase gene in the PYr-MirTarget luciferase vector (Ambion, Austin, TX, USA). The 3'-UTR of Atg5 and Beclin-1 (containing the binding sites for miR-30d-5p) were amplified from a cDNA library with the following primers: Atg-5 (forward, 5'-CTCGAGCCTTAATGAGAATTTCCTGTTTACAGTC-3' and reverse, 5'-GCGGCCGCGAACTCCTGAGACGAGTTCCCC-3'); Beclin-1 (forward, 5'-CTCGAGGGTAATATTAAACCACATGTTTACAATAC-3' and reverse, 5'-GCGGCCGCCCAGTGAAAACACATTAATGTC-3'). The mutant 3'-UTR of Beclin-1 and Atg5 (in which six nucleotides were mutated in the binding sites) were amplified using the following primer sequences: Atg-5 (forward, 5'-CTCGAGCCTTAATGAGAATTTCCTCAATGAAGTC-3' and reverse, 5'-GCGGCCGCGAACTCCTGAGACGAGTTCCCC-3'); Beclin-1 (forward, 5'-CTCGAGGGTAATATTAAACCACATCAATGAAATAC-3' and reverse, 5'-GCGGCCGCCCAGTGAAAACACATTAATGTC-3').
For luciferase assays, HEK293T cells were cultured in 24-well plates and co-transfected with 50 ng of the corresponding vectors containing firefly luciferase together with 25 ng of miR-30d-5p or control. Transfection was performed using Lipofectamine ® 2000 reagent (Invitrogen). At 48 h post-transfection, the relative luciferase activity was calculated by normalizing the firefly luminescence to the Renilla luminescence using the Dual-Luciferase Reporter Assay (Promega, Madison, WI, USA) according to the manufacturer's instructions.
Murine models of middle cerebral artery occlusion (MCAO)
Animals were anesthetized by intraperitoneal injection of pentobarbital sodium. Body temperature was monitored and maintained at 36.5 to 37.5 °C. A modified model of MCAO was used to create permanent focal ischemia, as previously described [26] . Briefly, the right middle cerebral artery (MCA) was occluded by inserting a monofilament nylon suture with a heat-rounded tip into the internal carotid artery, which was advanced further until it closed the origin of the MCA. Sham-operated rats underwent the same surgical procedure without insertion of the filament. To investigate the effect of exosomes from ADSCs on MCAOinduced cerebral injury, DiI-labeled exosomes (DiI-Exos) were resuspended in 0.9% saline and injected intravenously through the tail vein into ischemic rats at a concentration of 80 μg per 2 ml immediately after the ligation operation [28] . Rats were sacrificed 3 h or 72 h after injection and the brain sections were harvested.
Western blot analysis
Western blot analysis was carried out using cell lysates in urea buffer (8 M urea, 1 M thiourea, 0.5% 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS), 50 mM dithiothreitol, 24 mM spermine). Protein fractions were prepared using extraction reagents (Pierce, Rockford, IL, USA) following
Results
The expression of miR-30d-5p and inflammatory factor in serum were different in stroke patients The obtained data demonstrate that AIS did not alter blood Hb, RBC or PLT count, whereas a significant 70.5% increase in WBC count was observed in patients after AIS compared to the control values (Table 1 ). In addition, ESR in AIS exceeded control levels by more than 3-fold. No significant differences in serum TC, TG, HDL or LDL were detected between the studied groups. RT-PCR detection showed that the expression of miR-30d-5p was down-regulated after AIS (Fig. 1A) . The result was consistent with the findings of Zhao, et al [18] .. In addition, there is increasing evidence that the expression of miR-30d-5p is related to autophagy regulation [18] and inflammatory response [29] . ELISA detection showed that serum levels of the inflammatory factors TNF-α, IL-6 and iNOS were upregulated in AIS patients, while the anti-inflammatory factors IL-4 and IL-10 were down-regulated (Fig. 1B-F) . According to previous reports, TNF-α, IL-6 and iNOS might be involved in the inflammatory responses in acute cerebral infarction patients and are also M1 macrophage markers, while IL-4 and IL-10 are M2 macrophage markers [30] . Together the above results show that the M1 macrophage polarization of microglial cells is enhanced after AIS which promotes the inflammatory response. These findings suggest that expression of miR-30d-5p may be involved in inflammatory factor regulation.
Exos from miR-30d-5p-overexpressing ADSCs are more effective in suppressing OGDinduced autophagy in primary microglia
There is increasing evidence that autophagy has a regulatory function in inflammation as well as having an antiinflammatory effect [31, 32] . However some reports found that autophagy might 
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promote the inflammatory response by suppressing M2 macrophage polarization [33] [34] [35] . Consequently, we aimed to identify whether Exos from ADSCs have a therapeutic effect on the OGD-induced inflammatory response in primary microglia by promoting autophagy. Exosomes were purified from ADSCs which was isolated and positive for the mesenchymal stem cell (MSC) markers CD29, CD90, CD44, and CD105 and negative for the endothelial markers vWF (Fig. 2) , and their size distribution was determined to be slightly below 100 nm by dynamic light scattering (Fig. 3A) . Transmission electron microscopy was used to identify exosomes from the ADSC culture medium. Ultrastructural analysis of ADSC-derived exosomes confirmed that they have a diameter of around 100 nm (Fig. 3B) . Expression of the exosome markers CD9, CD63, CD81 and TSG101 was then confirmed by western blotting (Fig. 3C ). Fig. 2D shows representative micrographs of primary microglia containing positively-stained DiI-labelled exosomes and the absence of staining in primary microglia where exosomes have been denatured by boiling.
To compare the therapeutic effect between Exos and miR-30d-5p-Exos on ischemiainduced nerve injury, ADSCs were transfected with miR-30d-5p over-expression mimic, cultured for 48 h, and then harvested for RT-PCR analysis. The results showed that the expression of miR-30d-5p in both ADSCs and Exos was increased after transfection with miR-30d-5p mimic ( Fig. 4A and 4B) .
Primary microglia cells were treated with or without Exos (10 μg/mL) under OGD conditions for 6 h. Immunofluorescence images of cells double-stained with LC-3 (green) and Iba-1 (red) showed that LC3-puncta in primary microglia were increased after OGD induction compared with the control group. Exos treatment significantly suppressed the formation of autophagy plaques, especially in the miR-30d-5p-overexpressing Exos treatment group (Fig.  4C and 4D ). Western blot detection further confirmed that treatment with Exos, especially miR-30d-5p-overexpressing Exos, reversed the OGD-induced promotion of expression of the autophagy-related proteins Beclin-1, Atg-5 and LC-3, but increased P62 expression (Fig. 4E-I ). These findings suggest that the protective effect of Exos in ischemia-induced brain injury 
Treatment with miR-30d-5p-Exos is more effective in suppressing the inflammatory response by reversing OGD-induced and autophagy-mediated microglial polarization to M1.
To identify whether ischemia-induced brain injury is related to regulation of microglia activation and polarization, primary microglia cells were treated with/without Exos (10 μg/ mL) or 3-Ma (2 mM) under OGD conditions for 6 h, then collected for immunofluorescence analysis. The results show that Exos treatment reversed OGD-induced M1 microglia/ macrophage conversion, especially in the miR-30d-5p overexpressing Exos treatment group (Fig.. 5A and 5B), and promoted conversion of microglia into M2 microglia/macrophages (5C and 5D). Further, treatment with 3-Ma (an autophagy inhibitor) confirmed that the microglia/ macrophage polarization was related to autophagy. Suppression of autophagy can promote OGD-induced polarization of microglia into M2 microglia/macrophages. ELISA detection showed that Exos treatment reversed increases in the expression of the inflammatory factors TNF-α, IL-6 and iNOS, which are markers secreted by M1 microglia/macrophages. However, Exos treatment increased expression of IL-4 and IL-10, the markers secreted by M2 microglia/macrophages (Fig. 5E-I) . Treatment with Exos from miR-30d-5p-overexpressing ADSCs have a greater effect in suppressing inflammatory factor expression and promoting M2 microglial/macrophage conversion. These data suggest that the expression of miR-30d- 
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Cellular Physiology and Biochemistry 5p has a greater effect in inhibiting autophagy. These results were confirmed with 3-Ma treatment.
Both Beclin-1 and Atg5 are direct targets of miR-30d-5p
Possible interactions between miR-30d-5p and Beclin-1 or Atg5 were predicted by bioinformatics analysis (http://www.targetscan.org/). Overlap analyses showed that miR30d-5p had a broadly-conserved binding site (Fig. 6A) . A mutated version of both the Beclin-1 and Atg5 3′-UTR was constructed in which six complementary nucleotides in the binding site were altered (Fig. 6B and 6C ). This mutated construct was fused to the luciferase coding region (PYr-RGS-17 3′-UTR) and co-transfected into HEK293T cells along with miR-30d-5p mimic. The relative luciferase activity showed that when the wild-type Beclin-1 and Atg5 3′-UTR were co-transfected with miR-30d-5p mimic, expression of both Beclin-1 and Atg5 was significantly decreased (P < 0.001) compared with co-transfection with the control miRNA. However, this effect was not observed after transfection with the mutant 3′-UTR of Beclin-1 or Atg5, indicating that miR-30d-5p can specifically target and suppress the 3′-UTR of both Beclin-1 and Atg5 (Fig. 6D and 6E ). Western blot analyses further confirmed that miR-30d-5p overexpression significantly inhibited expression of both Beclin-1 ( Fig. 6F and 6G) and Atg5 ( Fig. 6H and 6I ) at the protein level in vitro. This suggests that miR-30d-5p-abundant Exos have a greater effect in suppressing autophagy.
Treatment with miR-30d-5p-Exos is more effective in ameliorating MCAO-induced brain injury
To identify the effects of Exos in ischemia-induced brain injury, stroke was induced in rats by MCAO, after which Exos were injected into the tail vein. At 3 h after stroke, brain 
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Cellular Physiology and Biochemistry coronal sections were harvested. Immunofluorescence images of the ischemic region show that Exos localize to the ischemic area (Fig. 7A) . Three days after stroke, M1/M2 microglia markers and infarct volume were measured using immunofluorescence and TTC staining, respectively. TTC staining showed that infarct volumes were significantly larger in the MCAO group compared with controls, but that Exos treatment significantly decreased MCAOinduced infarct volume, especially in the miR-30d-5p-overexpression group (Fig. 7B and 7C ).
Immunohistochemistry was used to detect apoptosis of nerve cells at 3 days after stroke ( Fig.  7D and 7E ). The assay results confirmed that Exos treatment reversed ischemia-induced neuronal apoptosis, especially in the miR-30d-5p overexpression group. 
miR-30d-5p-Exos treatment inhibits the autophagy-mediated inflammatory response by promoting microglia polarization to M2 after MCAO.
Immunofluorescence illuminated the effects of Exos on microglia/macrophage phenotypic responses in mice 3 days after stroke. Exos treatment reduced expression of the M1 marker, iNOS (Fig. 8A and 8B) , and increased expression of the M2 marker, CD206 (Fig. 8C and 8D) . Treatment with miR-30d-5p-overexpressing Exos had the best effect in promoting polarization of microglia into M2. Exos treatment also reversed the MCAOinduced expression of autophagy-related proteins Beclin-1, Atg5, and LC3 in brain tissue (Fig. 8E-I) . ELISA showed that Exos treatment decreased expression of TNF-α, IL-6 and iNOS, but increased IL-4 and IL-10 levels (Fig. 8J-N) .
Discussion
In this study, we have investigated whether ADSC-derived exosomes enriched with microRNA (miR)-30d-5p have a protective effect on AIS by examining their effect on cells from subjects with AIS and on an ischemic model in vivo and in vitro. Our main findings were as follows: (i) expression of the inflammatory cytokines TNF-α, IL-6 and iNOS are induced, while the anti-inflammatory cytokines IL-4, IL-10 and miR-30d-5p are reduced following AIS in both patients and animal models; (ii) in vitro studies demonstrate that suppression of autophagy significantly reduces the OGD-induced inflammatory response. In addition, exosome treatment is more effective in suppressing the inflammatory response by reversing the OGD-induced and autophagy-mediated microglial polarization to M1, and (iii) in vivo studies show that exosomes derived from ADSCs significantly decrease the cerebral injury area of infarction by suppressing autophagy and promoting M2 microglia/macrophage polarization.
Recent evidence suggests that microglia cells play an active role in normal brain function, and the importance of active neuronal-microglial interaction in the maintenance of homeostasis in the extracellular microenvironment has become increasingly appreciated [27] . The functions of microglia become more significant in response to a CNS insult such as ischemia. Increasing evidence suggests that an increase in the brain M2/M1 ratio and increases of M2 microglial proteins have anti-inflammatory properties and provide a neuroprotective effect [36, 37] . IL-4 and IL-10 are markers secreted by M2 microglial cells, while TNF-α, IL-6 and iNOS are markers secreted by M1 microglial cells [38] [39] [40] [41] . suggesting that M1 microglia are increased in AIS patients. We also found that the expression of miR30d-5p was decreased, which is related to autophagy regulation, while autophagy is related to the inflammatory response [42, 43] . The results show that miR-30d-5p can significantly suppress ischemia-induced autophagy by targeting both Beclin-1 and Atg5. Ultimately it suppresses ischemia-induced and autophagy-mediated microglial polarization to M1. Together, these data indicate that overexpression of miR-30d-5p may have an important regulatory role in neuroprotection.
Emerging data show that exosomes released from MSCs have therapeutic benefits in stroke. MSC-derived exosomes are capable of transferring miR-133b to neurons and subsequently contribute to neurite outgrowth after stroke [44, 45] . These data indicate that MSC-derived exosomes not only cross the blood-brain barrier (BBB), but also deliver functional cargo to modulate gene expression in the recipient cells. Due to their small size, exosomes can avoid phagocytosis by macrophages. They are naturally able to evade endosomal-lysosomal degradation, in contrast to polymeric nanoparticles and liposomes. Combined with their lack of immunogenicity, these features make exosomes promising candidates for gene drug delivery [46] . In our study, we found that exosomes from miR-30d-5p-overexpressing ADSCs suppressed ischemia-induced neuronal damage by inhibiting the autophagy-mediated inflammatory response in in vivo and in vitro experiments. Our results also found that the expression of miR-30d-5p can significantly inhibit both Beclin-1 and Atg5 expression by targeting the 3'UTR of Beclin-1 and Atg5 at the mRNA level. Suppression Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry of autophagy can transform microglial/macrophage polarization from M1 to M2 under ischemic conditions. These findings suggest that the protective effect of Exos in AIS-induced brain injury depends on regulation of autophagy and microglial/macrophage polarization. Exosome-mediated delivery of miR-30d-5p suppresses autophagy-mediated brain injury by promoting M2 microglial/macrophage polarization.
Conclusion
In summary, our results show that exosomes are efficient tools for gene drug delivery to the ischemic cortex. In addition, exosomes loaded with miR-30d-5p can reverse ischemiainduced, autophagy-mediated brain injury by promoting M2 microglial/macrophage polarization. Our study suggests that treatment with exosomes from miR-30d-5p-overexpressing ADSCs during the acute phase of stroke could be a promising therapeutic strategy for ameliorating cerebral injury by inhibiting the inflammatory response.
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